Recent Articles

• 
  Global Business

  Daewoong Pharma Launches Diabetes Drug Envlo in 8 MEA Nations

  ⓒNewsis Daewoong Pharmaceutical’s domestically developed diabetes treatment “Enblo” is entering eight major markets in the Middle East and Africa. Daewoong Pharmaceutical announced on the 2nd that it had signed an export supply contract for Enblo worth KRW 145.2 billion with Swiss pharmaceutical com

  2026.07.03
• 
  Medical / Research

  Depressed Women Under 45 Face 20% Higher Fatty Liver Risk

  A study has found that the more severe depressive symptoms are, the higher the risk of developing fatty liver. In particular, among women under 45, the association between depressive symptoms and fatty liver risk appeared more pronounced. Getty Images Bank The more severe depressive symptoms are, th

  2026.07.01
• 
  Global Trend

  Anthropic Enters AI Drug Race With Claude Science

  On the 30th (local time), Anthropic unveiled its automated drug discovery software (SW), “Claude Science,” at an event in San Francisco, United States. The company has entered the artificial intelligence (AI) drug development competition, a field where Google and OpenAI have taken an early lead. Wit

  2026.07.01
• 
  Medical / Research

  Seven Hours of Sleep? Data on 270,000 Challenge Belief

  Photo = Getty Images Bank Contrary to the common belief that “seven hours of sleep a day is necessary,” new research has found that there is no single “correct” sleep duration that can be uniformly applied to everyone.A joint research team from Sungshin Women’s University, Samsung Medical Center, Sa

  2026.06.30
• 
  Clinical Trial

  LG Chem Wins FDA Nod for Novel Cancer Drug Trial

  LG Chem is taking on the challenge of developing treatments in uncharted oncology areas where there are no approved therapies and where treatment and survival time extension remain limited. LG Chem announced on the 30th that it has received clearance from the U.S. Food and Drug Administration (FDA)

  2026.06.30
• 
  Bioprocessing / CDMO

  After Samsung, Celltrion, Lotte Joins Songdo Bio Cluster Expansion

  The scale of the “bio cluster” established in Songdo International City in Yeonsu-gu, Incheon, is expanding. According to the Incheon Free Economic Zone Authority on the 29th, Lotte Biologics (Lotte Bio) recently built its first Bio Campus plant in Songdo and obtained approval for its use. Lotte Bio

  2026.06.30
• 
  Diagnostics / Monitoring

  Single Blood Drop May Open New Alzheimer’s Path

  Getty Images Bank A domestic research team has developed a technology that identifies high‑risk groups for Alzheimer’s disease by analyzing genetic information in the blood. It is expected to help reduce the burden of existing diagnoses, which have relied on expensive imaging tests or invasive cereb

  2026.06.30
• 
  Biopharma

  Lilly, Samsung Biologics to Build Songdo Biotech Hub

  Perspective view of “LGL Incheon (C-Lab Outside),” scheduled for completion in July next year. Provided by Samsung Biologics On the 25th (local time), at the Torrey Pines life sciences cluster in northern San Diego, United States. Located about a 20-minute drive from the San Diego Convention Center,

  2026.06.30
• 
  Pharmaceutical R&D

  SK Chemicals, J2H Partner on NASH Drug Candidate

  At BIO USA, Park Hyun-seon, Head of Business at SK Chemicals (right), and Chung Ki-won, Executive Vice President of J2H Biotech, pose for a commemorative photo after signing a Letter of Intent for a strategic partnership on the domestic and overseas development and commercialization of “J2H-1702.” P

  2026.06.29
• 
  Bioprocessing / CDMO

  Korean Biotech Firms Pursue Global Deals at Bio USA

  The world’s largest pharmaceutical and biotech exhibition, the “2026 BIO International Convention (BIO USA),” has become a stage for Korean contract development and manufacturing organization (CDMO) companies to compete for global orders by highlighting their technological capabilities and strategie

  2026.06.26